Meeting
2019 ASCO Annual Meeting
p53 and p16 expression profiles reveal three prognostically relevant subgroups in vulvar cancer: A TMA based study by the AGO-CaRE-translational study group.
Authors
Linn Lena Woelber
AGO & Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Germany, Hamburg, Germany
Linn Lena Woelber , Katharina Prieske , Christine Eulenburg , Nikolaus de Gregorio , Rüdiger Klapdor , Matthias Kalder , Elena Ioana Braicu , Sophie Fuerst , Maximillian Klar , Hans-Georg Strauss , Grit Mehlhorn , Werner Meier , Atanas Ignatov , Alexander Mustea , Julia Kathrin Jueckstock , Georg Schmidt , Dirk Bauerschlag , Martin Hellriegel , Sven Mahner , Eike Burandt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Other Gynecologic Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5592)
DOI
10.1200/JCO.2019.37.15_suppl.5592
Abstract #
5592
Poster Bd #
415
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
FGFR3 correlation with mutant p53 and its prognostic value in oropharyngeal squamous cell carcinoma (OPSCC).
First Author: Zhuo Georgia Chen
Poster
2023 ASCO Annual Meeting
The proliferation biomarker SPAG5 expression in HER2 low and HER2 overexpression early breast cancer (BC) predicting tumour response to neoadjuvant chemotherapy (NACT) with and without trastuzumab.
First Author: Tarek Mohamed Ahmed Abdel-Fatah
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
First Author: William Gesztes
Poster
2023 ASCO Genitourinary Cancers Symposium
An assessment of the penile squamous cell carcinoma surfaceome for therapeutic target discovery.
First Author: George Daniel Grass